Accounts Receivable, after Allowance for Credit Loss, Current in USD of Core Laboratories Inc. /DE/ from Q4 2022 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Summary
Core Laboratories Inc. /DE/ quarterly Accounts Receivable, after Allowance for Credit Loss, Current history and change rate from Q4 2022 to Q3 2025.
  • Core Laboratories Inc. /DE/ Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending 30 Sep 2025 was $110M, a 6.24% decline year-over-year.
Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)
Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Change (%)

Core Laboratories Inc. /DE/ Quarterly Accounts Receivable, after Allowance for Credit Loss, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $110M -$7.33M -6.24% 30 Sep 2025 10-Q 23 Oct 2025
Q2 2025 $114M -$1.74M -1.5% 30 Jun 2025 10-Q 25 Jul 2025
Q1 2025 $117M +$1.94M +1.69% 31 Mar 2025 10-Q 28 Apr 2025
Q4 2024 $112M +$2.41M +2.2% 31 Dec 2024 10-Q 23 Oct 2025
Q3 2024 $118M +$13.5M +13% 30 Sep 2024 10-Q 24 Oct 2024
Q2 2024 $116M +$8.83M +8.27% 30 Jun 2024 10-Q 25 Jul 2024
Q1 2024 $115M 31 Mar 2024 10-Q 25 Apr 2024
Q4 2023 $109M +$2.44M +2.28% 31 Dec 2023 10-K 13 Feb 2025
Q3 2023 $104M 30 Sep 2023 10-Q 02 Nov 2023
Q2 2023 $107M 30 Jun 2023 10-Q 27 Jul 2023
Q4 2022 $107M 31 Dec 2022 10-K 15 Feb 2024
* An asterisk sign (*) next to the value indicates that the value is likely invalid.